Arriaga-Pizano L, Ramírez-Ramírez D, Prieto-Chávez J, Pelayo R, Ruiz-Argüelles A

Language: Spanish
References: 23
Page: 20-29
PDF size: 217.20 Kb.

ABSTRACT

Recommendations for the typing of hematological malignancies in Latin America were published in 2005. Carrying out a national meeting to update them was deemed necessary. 95 professional experts on the subject were invited in order to analyze and contrast alternatives and reach a consensus. Consensus opinions were reached regarding indications, sample types and processing, antibodies, nomenclature and reporting of results for the diagnosis and monitoring of acute leukemias. This paper describes the recommendations and emphasizes on the need for national laboratories to adhere to them.

REFERENCES

1. Pérez-Saldívar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Martínez-Ávalos A, Medina-Sanson A, Espinosa-Hernández L, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11:355.

2. Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012;30:751-757.

3. Vilchis-Ordoñez A, Dorantes-Acosta E, Vadillo E, López-Martínez B, Pelayo R. Early hematopoietic differentiation in acute lymphoblastic leukemia: the interplay between leukemia-initiating cells and abnormal bone marrow microenvironment. En: Mejía-Aranguré JA , editor. Etiology of acute leukemias in children. México: Springer; 2016.

4. Dorantes-Acosta E, Pelayo R. Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res. 2012;2012:406796.

5. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer. 2003; 97:2229-2235.

6. Mejía-Aranguré JM, Núñez-Enríquez JC, Fajardo-Gutiérrez A, Rodriguez- Zepeda MD, Martin-Trejo JA, Duarte-Rodriguez DA, et al. Descriptive epidemiology of children with acute myeloid leukemia residing in Mexico City: a report from the Mexican Inter-Institutional Group for Identifying Childhood Leukemia Causes. Gac Med Mex. 2016;152:66-77.

7. Balandrán JC, Vadillo E, Dozal D, Reyes-López A, Sandoval-Cabrera A, Laffont-Ortiz MD, et al. Analysis of normal hematopoietic stem and progenitor cell contents in childhood acute leukemia bone marrow. Arch Med Res. 2016;47:629-643.

8. Izraeli S. Similar yet different. Blood. 2010;116:1019-20.

9. Juárez-Velázquez R, Reyes-León A, Salas-Labadía C, Rivera-Luna R, Velasco-Hidalgo L, López-Hernández G, et al. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2014;55:2305-2311.

10. Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998;16(12):3768-3773.

11. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital. Blood. 2009;113:5083-5089.

12. Meijerink JP, Den-Boer ML, Pieters R. New genetic abnormalities and treatment response in acute lymphoblastic leukemia. Semin Hematol. 2009;46:16-23.

13. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol. 2008;26 2813-2820.

14. Rajendran P, Dalerba, P. Theoretical and experimental foundations of the “cancer stem cell” model. En: Rajasekhar V, editor. Cancer stem cells. EE. UU.: Wiley-Blackwell; 2014.

15. Chávez-González A, Avilés-Vázquez S, Moreno-Lorenzana D, Mayani H. Hematopoietic stem cells in chronic myeloid leukemia. En: Alimoghaddam K, editor. Stem cell biology in normal life and diseases. Croacia: IntechOpen; 2013.

16. Chung SS, Park, CY. Acute myeloid leukemia cells-updates and controversies. En: Rajasekhar V (editor). Cancer stem cells. EE. UU.: Wiley- Blackwell; 2014.

17. Raff T, Bruggermann, M. Leukemia-initiating cells in acute lymphoblastic leukemia. En: Rajasekhar V (editor). Cancer stem cells. EE. UU.: Wiley- Blackwell; 2014.

18. Balandrán JC, Purizaca J, Enciso J, Dozal D, Sandoval A, Jiménez-Hernández E, et al. Pro-inflammatory-related loss of CXCL12 niche promotes acute lymphoblastic leukemic progression at the expense of normal lymphopoiesis. Front Immunol. 2016;7:666.

19. Ruiz-Argüelles A, Duque RE, Orfao A. Report on the first Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia. Cytometry. 1998;34:39-42.

20. Ruiz-Argüelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A, Latin American Consensus Conference. Report on the second Latin American Consensus Conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry B Clin Cytom. 2006;70:39-44.

21. EuroFlow. Standard Operating Protocol (SOP) for Bulk Lysis for MRD panels (versión 1.1) 2014. Disponible en http://medtechtrading.ch/data/ documents/BulkLysisProtocol.pdf

22. Haydu JE, Ferrando AA. Early T-cell precursor acute lymphoblastic leukaemia. Curr Opin Hematol. 2013;20:369-373.

23. Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129 572-581.